Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
In August 2025, the FDA accepted numerous anti-cancer therapies throughout a variety of illness varieties, reminiscent of colorectal, lung most cancers and mind...
The FDA authorized Bildyos and Bilprevda as biosimilars to Prolia and Xgeva, increasing bone care choices for osteoporosis, most cancers and extra.The U.S....
Regardless of having a excessive chance of recurrence, platinum-resistant ovarian most cancers now has a useful therapy possibility with Elahere (mirvetuximab soravtansine-gynx), an...
